Role of oral zinc supplementation for reduction of neonatal hyperbilirubinemia: a systematic review of current evidence

References

• Maisels MJ. Managing the jaundiced newborn: a persistent challenge. CMAJ 2015;187:335–43
   PubMed Web of Science ®Google Scholar
• Bhutani VK, Zipursky A, Blencowe H, et al. Neonatal hyperbilirubinemia and rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res 2013;74:86–100
   PubMed Web of Science ®Google Scholar
• GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet Lond Engl 2015;385:117–71
   PubMed Web of Science ®Google Scholar
• Lawn JE, Blencowe H, Oza S, et al. Every newborn: progress, priorities, and potential beyond survival. Lancet 2014;384:189–205
   PubMed Web of Science ®Google Scholar
• Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008;358:920–8
   PubMed Web of Science ®Google Scholar
• Suresh GK, Martin CL, Soll RF. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates. Cochrane Database Syst Rev 2003;2:CD004207
   PubMedGoogle Scholar
• Kemper K, Horwitz RI, McCarthy P Decreased neonatal serum bilirubin with plain agar: a meta-analysis. Pediatrics 1988;82:631–8
   Google Scholar
• Gholitabar M, McGuire H, Rennie J, et al. Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. Cochrane Database Syst Rev 2012;12:CD009017
   PubMed Web of Science ®Google Scholar
• Mishra S, Cheema A, Agarwal R, et al. Oral zinc for the prevention of hyperbilirubinaemia in neonates. Cochrane Database Syst Rev 2015;7:CD008432
   PubMed Web of Science ®Google Scholar
• Amitai Y, Regev M, Arad I, et al. Treatment of neonatal hyperbilirubinemia with repetitive oral activated charcoal as an adjunct to phototherapy. J Perinat Med 1993;21:189–94
   PubMed Web of Science ®Google Scholar
• Davis DR, Yeary RA. Activated charcoal as an adjunct to phototherapy for neonatal jaundice. Dev Pharmacol Ther 1987;10:12–20
   PubMedGoogle Scholar
• Kumar R, Narang A, Kumar P, Garewal G. Phenobarbitone prophylaxis for neonatal jaundice in babies with birth weight 1000–1499 grams. Indian Pediatr 2002;39:945–51
   PubMedGoogle Scholar
• Murki S, Dutta S, Narang A, et al. A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates. J Perinatol 2005;25:325–30
   PubMedGoogle Scholar
• Arya VB, Agarwal R, Paul VK, Deorari AK. Efficacy of oral phenobarbitone in term “at risk” neonates in decreasing neonatal hyperbilirubinemia: a randomized double-blinded, placebo controlled trial. Indian Pediatr 2004;41:327–32
   PubMedGoogle Scholar
• Bisceglia M, Indrio F, Riezzo G, et al. The effect of prebiotics in the management of neonatal hyperbilirubinaemia. Acta Pædiatr 2009;98:1579–81
   PubMed Web of Science ®Google Scholar
• Armanian AM, Barekatain B, Hoseinzadeh M, Salehimehr N. Prebiotics for the management of hyperbilirubinemia in preterm neonates. J Matern Fetal Neonatal Med 2016;29:3009–13
   PubMed Web of Science ®Google Scholar
• Mundy CA. Intravenous immunoglobulin in the management of hemolytic disease of the newborn. Neonatal Netw NN 2005;24:17–24
   PubMedGoogle Scholar
• Demirsoy U, Nalbantoğlu B, Nalbantoğlu A, et al. Effect of fluid supplementation on serum bilirubin level during phototherapy of exclusively breastfed term infants with hyperbilirubinemia. Breastfeed Med 2011. [Epub ahead of print]
   PubMedGoogle Scholar
• Boo N-Y, Lee H-T. Randomized controlled trial of oral versus intravenous fluid supplementation on serum bilirubin level during phototherapy of term infants with severe hyperbilirubinaemia. J Paediatr Child Health 2002;38:151–5
   PubMed Web of Science ®Google Scholar
• Hakan N, Zenciroglu A, Aydin M, et al. Exchange transfusion for neonatal hyperbilirubinemia: an 8-year single center experience at a tertiary neonatal intensive care unit in Turkey. J Matern Fetal Neonatal Med 2015;28:1537–41
   PubMed Web of Science ®Google Scholar
• Murki S, Kumar P. Blood exchange transfusion for infants with severe neonatal hyperbilirubinemia. Semin Perinatol 2011;35:175–84
   PubMed Web of Science ®Google Scholar
• Altunhan H, Annagür A, Tarakçi N, et al. Fully automated simultaneous umbilical arteriovenous exchange transfusion in term and late preterm infants with neonatal hyperbilirubinemia. J Matern Fetal Neonatal Med 2016;29:1274–8
   PubMed Web of Science ®Google Scholar
• Méndez-Sánchez N, Roldán-Valadez E, Flores MA, et al. Zinc salts precipitate unconjugated bilirubin in vitro and inhibit enterohepatic cycling of bilirubin in hamsters. Eur J Clin Invest 2001;31:773–80
   PubMed Web of Science ®Google Scholar
• Vítek L, Muchová L, Zelenka J, et al. The effect of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. J Pediatr Gastroenterol Nutr 2005;40:135–40
   PubMed Web of Science ®Google Scholar
• Méndez-Sánchez N, Martínez M, González V, et al. Zinc sulfate inhibits the enterohepatic cycling of unconjugated bilirubin in subjects with Gilbert’s syndrome. Ann Hepatol 2002;1:40–3
   PubMedGoogle Scholar
• Cochrane handbook for systematic reviews of interventions [Internet]. Available from: http://handbook.cochrane.org/ [last accessed 25 Apr 2016]
   Google Scholar
• Patton DR, Sukadi A. Effect of oral zinc on hyperbilirubinemia in full term neonates. Paediatr Indones 2011;51:107–10
   Google Scholar
• Babaei H, Hemmati M, Fallahi V, Rezaei M. Effect of oral zinc sulfate in prevention of jaundice in healthy term newborns. J Kermanshah Univ Med Sci J Kermanshah Univ Med Sci 2014;17:680–6
   Google Scholar
• Maamouri G, Boskabadi H, Mafinejad S, et al. Efficacy of oral zinc sulfate intake in prevention of neonatal jaundice. Iran J Neonatol IJN 2013;4:11–16
   Google Scholar
• Mohammadzadeh A, shah FA, Alizadeh kaseb A, et al. Prophylactic effect of zinc sulfate on hyperbilirubinemia in premature very low birth weight neonates: a randomized clinical trial. Iran J Neonatol IJN 2015;5:6–10
   Web of Science ®Google Scholar
• Kumar A, Bagri NK, Basu S, Asthana RK. Zinc supplementation for neonatal hyperbilirubinemia: a randomized controlled trial. Indian Pediatr 2014;51:375–8
   PubMed Web of Science ®Google Scholar
• Rana N, Mishra S, Bhatnagar S, et al. Efficacy of zinc in reducing hyperbilirubinemia among at-risk neonates: a randomized, double-blind, placebo-controlled trial. Indian J Pediatr 2011;78:1073–8
   PubMed Web of Science ®Google Scholar
• IRCT: Effect of oral zinc on hyperbilirubinemia on LBW premature neonates admitted in NICU [Internet]. Available from: http://www.irct.ir/searchresult.php?keyword=&id=1162&number=22&prt=6194&total=10&m=1 [last accessed 26 Apr 2016]
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097
   PubMed Web of Science ®Google Scholar